Study # MDA 2024-1159

EXtending outcomes for PAncreas cancer patients with Nominal oligometastatic Disease (EXPAND): A randomized phase III trial

Study Status:

Enrolling

Treatment Agent:

Radiation Therapy

Description

Short Title: MDA 2024-1159/EXPAND

The EXPAND trial (EXtending outcomes for PAncreas cancer patients with Nominal oligometastatic Disease) is a randomized phase III trial assessing the efficacy of MDT to improve PFS and OS for patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC).

Resources and Links

National Clinical Trial Identified Number: NCT06593431

Information and next steps

Disease:

  • Pancreas Cancer,
  • Oligometastatic

Study Phase:

III

Physician Name:

Department:

Ask a Question